High Incidence of Thromboembolic Events in Patients Who Died of COVID-19
Limited tablet cardiac ultrasound was found to represent an effective alternative to standard platform imaging for the screening of COVID-19-related cardiac conditions.
All articles by Brandon May
ACC Expert Consensus Decision Pathway for Mitral Regurgitation Management: 2020 Update
The ACC published a focused update of the 2017 expert consensus decision pathway on the management of mitral regurgitation.
Apremilast Improves Psoriatic Disease and Cardiometabolic Markers
A novel study assesses the safety and efficacy of apremilast in patients with psoriasis and evaluates the treatment as a metabolic modulator.
Modest Reductions in LDL-C in ASCVD Associated With Low Adherence, Prescribing of High-Intensity Statin Therapy
Suboptimal adherence to and low prescribing of high-intensity statin therapy may be associated with the modest reductions in LDL-C observed in patients with ASCVD.
Greater 5-Year Survival With Heart Transplant With or Without Bridge to Transplant LVAD vs LVAD Destination Therapy
Heart transplant with or without bridge to transplant LVAD therapy was found to be associated with greater 5-year survival compared with LVAD destination therapy in patients with end-stage heart failure.
Early Up-Titration to High-Intensity Statins May Reduce CV Events in Patients at Very High Risk for Atherosclerotic CVD
Up-titration to high-intensity statins early on in the course of treatment was found to be associated with a lower risk for cardiovascular (CV) events compared with no up-titration in patients at very high risk for CV disease.
NT-proBNP Ratio May Improve Prognosis in Elderly Patients With Valvular Heart Disease
The N-terminal pro–B-type natriuretic peptide ratio may improve prognosis in elderly patients with moderate to severe valvular heart disease.
Reoperative Cardiac Surgery May Predict Short- and Long-Term Mortality
Reoperative cardiac surgery was found to predict short- and long-term mortality.
Alirocumab Shows Long-Term Safety and Efficacy in Patients With Statin Intolerance
Alirocumab was found to be well tolerated and to produce long-term reductions in low-density lipoprotein cholesterol in patients who are intolerant to statins.
ESC Releases Position Statement on Lipid Management in Rheumatoid Arthritis
The Cardiovascular Pharmacotherapy Working Group of the European Society of Cardiology suggest using principles similar to the current recommendations for diabetes, but applied to rheumatoid arthritis.
Next post in Dyslipidemia
